On the public citation graph

Inadequate response to ustekinumab in atopic dermatitis – a report of two patients

0 signed · 61 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.ad.2013.05.003openalex-snapshot
Ustekinumab en el tratamiento de la dermatitis atópica severa. Nuestra experiencia en 4 pacientes. Informe preliminar
inferredcites →https://doi.org/10.1016/j.coi.2011.09.006openalex-snapshot
IL-17 producing cells in host defense and atopy
inferredcites →https://doi.org/10.1016/j.iac.2010.05.001openalex-snapshot
The Infectious Aspects of Atopic Dermatitis
inferredcites →https://doi.org/10.1016/j.immuni.2008.11.009openalex-snapshot
Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
inferredcites →https://doi.org/10.1016/j.jaci.2013.04.046openalex-snapshot
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
inferredcites →https://doi.org/10.1056/nejmoa1104200openalex-snapshot
Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema
inferredcites →https://doi.org/10.1111/j.1365-4632.2011.05195.xopenalex-snapshot
Treatment of severe refractory adult atopic dermatitis with ustekinumab
inferredcites →https://doi.org/10.5021/ad.2013.25.3.368openalex-snapshot
Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4797649openalex-extracted
Unveiling New Protein Biomarkers and Therapeutic Targets for Inflammatory Skin Diseases Through Integrated Analysis of Human Plasma Proteomics and Genomics
inferred← citeshttps://doi.org/10.1007/978-3-319-66884-0_31openalex-snapshot
Biologics for the Treatment of Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/978-981-95-3791-4_35openalex-snapshot
Ustekinumab
inferred← citeshttps://doi.org/10.1007/s00005-017-0487-1openalex-snapshot
Novel Therapeutic Approaches to Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s00005-018-0521-yopenalex-snapshot
Systemic Treatment for Severe Atopic Dermatitis
inferred← citeshttps://doi.org/10.1007/s00281-015-0524-2openalex-snapshot
The continuing evolution of targeted therapy for inflammatory skin disease
inferred← citeshttps://doi.org/10.1007/s00403-021-02262-7openalex-snapshot
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review
inferred← citeshttps://doi.org/10.1007/s13555-016-0170-1openalex-snapshot
Systemic Treatment of Adult Atopic Dermatitis: A Review
inferred← citeshttps://doi.org/10.1007/s40257-016-0205-5openalex-snapshot
Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update
inferred← citeshttps://doi.org/10.1007/s40259-017-0241-6openalex-snapshot
Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential
inferred← citeshttps://doi.org/10.1016/j.alit.2015.06.003openalex-snapshot
Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy
inferred← citeshttps://doi.org/10.1016/j.anai.2017.09.061openalex-snapshot
Clinical approach to the patient with refractory atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.det.2017.02.006openalex-snapshot
An Update on the Pathophysiology of Atopic Dermatitis
inferred← citeshttps://doi.org/10.1016/j.iac.2016.08.015openalex-snapshot
Infectious Complications in Atopic Dermatitis
inferred← citeshttps://doi.org/10.1016/j.it.2015.10.006openalex-snapshot
The Multi-Modal Immune Pathogenesis of Atopic Eczema
inferred← citeshttps://doi.org/10.1016/j.jaad.2016.07.047openalex-snapshot
Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression
inferred← citeshttps://doi.org/10.1016/j.jaci.2015.08.015openalex-snapshot
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
inferred← citeshttps://doi.org/10.1016/j.jaci.2016.06.010openalex-snapshot
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
inferred← citeshttps://doi.org/10.1016/j.jaci.2017.03.012openalex-snapshot
Biologics in patients with skin diseases
inferred← citeshttps://doi.org/10.1016/j.jaip.2017.08.031openalex-snapshot
Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines
inferred← citeshttps://doi.org/10.1080/09546634.2017.1406894openalex-snapshot
A systematic review of ustekinumab in the treatment of atopic dermatitis
inferred← citeshttps://doi.org/10.1080/09546634.2021.1914315openalex-snapshot
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence
inferred← citeshttps://doi.org/10.1080/14712598.2022.2026920openalex-snapshot
Biological medication in atopic dermatitis
inferred← citeshttps://doi.org/10.1080/1744666x.2019.1560267openalex-snapshot
Atopic dermatitis: a review of evolving targeted therapies
inferred← citeshttps://doi.org/10.1097/md.0000000000043447openalex-snapshot
Associations of 2923 plasma proteins with incident atopic dermatitis in a prospective cohort study and genetic analysis
inferred← citeshttps://doi.org/10.1097/mop.0000000000000489openalex-snapshot
Rash diagnostics: an update on the diagnosis of allergic rashes
inferred← citeshttps://doi.org/10.1111/1346-8138.14295openalex-snapshot
Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases
inferred← citeshttps://doi.org/10.1111/all.13065openalex-snapshot
Anti‐inflammatory therapies in atopic dermatitis
inferred← citeshttps://doi.org/10.1111/bjd.15262openalex-snapshot
Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients
inferred← citeshttps://doi.org/10.1111/bjd.15493openalex-snapshot
Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study
inferred← citeshttps://doi.org/10.1111/ced.12847openalex-snapshot
Use of ustekinumab for severe refractory atopic dermatitis in a young teenager
inferred← citeshttps://doi.org/10.1111/dth.15814openalex-snapshot
New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: The role of systemic treatments as a possible trigger
inferred← citeshttps://doi.org/10.1111/dth.15910openalex-snapshot
Off‐label uses of ustekinumab
inferred← citeshttps://doi.org/10.1111/exd.13112openalex-snapshot
Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis
inferred← citeshttps://doi.org/10.1111/exd.70161openalex-snapshot
Exploring Novel Biomarkers for Rosacea Through Cohort Study and Mendelian Randomisation
inferred← citeshttps://doi.org/10.1111/jdv.14673openalex-snapshot
Immune response patterns in non‐communicable inflammatory skin diseases
inferred← citeshttps://doi.org/10.1111/jdv.14888openalex-snapshot
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
inferred← citeshttps://doi.org/10.1111/jdv.14891openalex-snapshot
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
inferred← citeshttps://doi.org/10.1159/000484406openalex-snapshot
Emerging Treatment Options in Atopic Dermatitis: Systemic Therapies
inferred← citeshttps://doi.org/10.1177/0976500x241240643openalex-snapshot
Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective
inferred← citeshttps://doi.org/10.1177/247553031600200105openalex-snapshot
Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part I
inferred← citeshttps://doi.org/10.1177/247553031700200205openalex-snapshot
Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part II
inferred← citeshttps://doi.org/10.14218/jerp.2022.00044openalex-snapshot
Ustekinumab in Dermatology: Approved Indications and Off-label Uses
inferred← citeshttps://doi.org/10.14800/rci.1173openalex-snapshot
Anti-interleukin and associated receptors monoclonal antibodies therapy in autoimmune diseases
inferred← citeshttps://doi.org/10.1515/jbcpp-2021-0165openalex-snapshot
Methotrexate related cutaneous adverse drug reactions: a systematic literature review
inferred← citeshttps://doi.org/10.1517/14728214.2016.1146681openalex-snapshot
Target-oriented therapy: Emerging drugs for atopic dermatitis
inferred← citeshttps://doi.org/10.17816/dv81397openalex-snapshot
Current approaches to the treatment of atopic dermatitis: a review of the literature
inferred← citeshttps://doi.org/10.2147/ptt.s492205openalex-snapshot
Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1452801openalex-snapshot
Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics
inferred← citeshttps://doi.org/10.3390/ijms21041314openalex-snapshot
The Role of Th17-Related Cytokines in Atopic Dermatitis
inferred← citeshttps://doi.org/10.3892/etm.2018.6989openalex-snapshot
Biological therapies for atopic dermatitis: An update�(Review)
inferred← citeshttps://doi.org/10.4103/ijpd.ijpd_24_21openalex-snapshot
Biologics in pediatric dermatology
inferred← citeshttps://doi.org/10.5694/mja17.00463openalex-snapshot
Atopic dermatitis: the new frontier
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.